Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gaucher Disease Registry Protocol

NCT00358943 is registered in ClinicalTrials.gov with Genzyme, a Sanofi Company as lead sponsor.

NCT NCT00358943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00358943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gaucher Disease Registry Protocol
Lead sponsor
Genzyme, a Sanofi Company
Phase
Observational
Overall status
Recruiting
Start date
April 1, 1991
Completion date
January 31, 2034
Enrollment
12,000 (estimated)
Sites
317

Conditions

As the registry lists them; a condition with its own page is linked.

cerebroside lipidosis syndrome, gaucher disease, glucocerebrosidase deficiency disease, glucosylceramide beta-glucosidase deficiency disease